Instructions for authors

Instructions for authors

Article types

Type Description Notes
Editorial By invitation of the editors-in-chief —
Original article Research papers. IMRaD structure. Clinical trial registration mandatory (see 2.6) CONSORT if clinical trial
Review Systematic reviews: PRISMA mandatory. Narrative reviews: PRISMA recommended (EQUATOR network) —
Brief article / Short communication Works that, due to methodology or case series, do not qualify as original articles —
Case report / Case series When they provide clear clinical or methodological value CARE checklist
Special article Articles on relevant topics, at the discretion of the editors-in-chief —
Summaries of works by SED members Summaries of works published in high-impact factor journals —
Letter to the editor Brief communications; comments on published articles —
Clinical image Images of clinical or educational interest —

Manuscript preparation

General format

  • A4 document, 1.5 or double spacing, legible font, continuous pagination
  • Main manuscript without authorship data (anonymised for double-blind review)
  • Title page as the first page of the document, separate from the manuscript body

Structure (original articles): IMRaD

  • Introduction, Material and methods, Results, Discussion, Conclusions

Title page

  • Title in Spanish and English (concise and informative)
  • Authors: first name, last name, full affiliation (institution, city, country)
  • ORCID for each author (mandatory), in URL format
  • Corresponding author: name, email, institutional postal address

Abstract and keywords

  • Abstract in Spanish and English (mandatory, bilingual)
  • Structured abstract for original articles (Objective / Methods / Results / Conclusions)
  • Keywords: 3-6, in Spanish and English, preferably based on MeSH/DeCS

Tables

  • As editable text (Word), not as images
  • Consecutive numbering, title and footnotes

Figures

  • High resolution (minimum 300 DPI)
  • Consecutive numbering, descriptive figure caption
  • Define symbols and abbreviations

Cover letter

The cover letter must accompany the manuscript. Copying the abstract is not recommended; instead, authors are encouraged to explain the potential impact of the work in their own words. The cover letter should include:

Context and objective. Brief summary of the problem investigated and the main objective of the study.

Results and significance. Authors are encouraged to address some or all of the following questions:

  • What are the key findings and why are they important for the scientific community?
  • How does this manuscript contribute to improving existing knowledge?
  • What questions does this manuscript answer?
  • How might it change clinical practice?

Authors are encouraged to identify the most relevant, original and/or valuable aspects of the work.

Fit with the journal. Explicitly explain why the manuscript aligns with the objectives and scope of RESED and why it will be of interest to its readership.

Additional declarations to be included in the letter:

  • That the manuscript is original and is not published or under review elsewhere
  • If it is a preprint, this must be stated (see section 2.9)
  • Previous conference presentations, if applicable

Languages

RESED accepts manuscripts in Spanish or English. The title, abstract and keywords must be presented in both languages.

Mandatory declarations (at the end of the manuscript)

Include in the following order:

  1. Author contributions (CRediT): detail the specific contribution of each author using the CRediT taxonomy. Translators are mentioned in the acknowledgements, never as authors.
  2. Conflicts of interest: mandatory declaration. If none exist: "Conflicts of interest: there are no conflicts of interest".
  3. Funding: declare all sources and the role of the funder in design, analysis, writing or decision to publish. If there was no funding: "This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors".
  4. Ethical approval and consent (if applicable)
  5. Data/code/materials availability (Data Availability Statement)
  6. Preprints (if applicable)
  7. Use of generative AI (if applicable)

Research ethics

Studies in humans

  • State ethics committee approval (name, institution and reference)
  • Declare that informed consent was obtained where applicable
  • In cases with risk of identification, require explicit consent for publication
  • The author must retain the written consents

Clinical trials

  • Mandatory registration in a recognised public registry (e.g. ClinicalTrials.gov or others accepted by the ICMJE) before or at the start of recruitment
  • Include the registration number in the manuscript and in the abstract
  • Mandatory CONSORT checklist (including flow diagram)

Animal studies

  • Ethics committee approval mandatory; include file number and date
  • State applicable animal welfare regulations and guidelines (ARRIVE)
  • Describe housing conditions, welfare measures and sex balance

Diversity in studies

  • Considering the diversity of study populations is recommended (not mandatory)

Informed consent

  • Requested when doubt arises while reading the manuscript. It is not a generalised initial requirement, except for clinical trials.

Case reports

  • Do not require ethics committee approval (they are not research studies).

Checklists by study type

  • CONSORT (clinical trials
  • PRISMA (systematic reviews/meta-analyses)
  • STROBE (observational studies)
  • CARE (case reports)
  • COREQ (qualitative studies)
  • STARD (diagnostic studies)
  • ARRIVE (animal studies)
  • General reference: EQUATOR network (www.equator-network.org)

Authorship, ORCID and CRediT

  • Authorship (ICMJE): each author must have made a substantive contribution and approved the final version
  • CRediT (mandatory): specify each author's contribution according to the CRediT taxonomy
  • ORCID (mandatory): all authors must include their ORCID iD in URL format
  • Translators: in the acknowledgements, never as authors
  • Corresponding author: responsible for communications and for ensuring the conformity of all co-authors

Use of artificial intelligence (AI)

  • AI cannot be listed as an author
  • If AI is used for writing, translating, summarising, data analysis, code generation or image editing, this must be explicitly declared: tool used, purpose, scope and subsequent human review
  • The AI use declaration is included in the mandatory declarations at the end of the manuscript

Originality, prior publication and preprints

  • The manuscript must be original and must not be published or under simultaneous review elsewhere
  • If the work was partially or fully presented at a conference, this must be declared
  • Preprints: accepted, provided this is stated in the cover letter. After final publication, the author must update the preprint record with the definitive reference

References

  • Vancouver style
  • Cite in the text with consecutive numbering in order of appearance
  • DOI mandatory when available, in active URL format (https://doi.org/...)

Manuscript submission

Manuscripts are submitted exclusively through the editorial platform: https://resed.es/index.php/resed/es/submission

The submission must include:

  • Document 1:
    • Main manuscript (anonymised, in Word): without authorship data. Tables included in the document; figures in high resolution (minimum 300 DPI)
  • Document 2:
    • Title page(within the same document, as a separate first page): title in Spanish and English, full list of authors with their affiliations (institution, city, country), ORCID of each author and corresponding author details (name, email, institutional postal address).
    • Mandatory declarations (at the end of the manuscript, see section 2.5): CRediT, conflicts of interest, funding, ethics, data availability, preprints, AI use
  • Document 3:
    • Cover lettern (see section 2.3)
  • Document 4:
    • Supplementary material (if applicable)